SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3oz6'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HPV_B_478B200_1 (HIV-1 PROTEASE)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	5 / 9	LEU A 225 GLY A 218 ILE A 140 ILE A 119 ILE A 224	None	1.00A	1hpvA-3oz6A: undetectable	1hpvA-3oz6A: 14.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1IEP_B_STIB202_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	4 / 7	LYS A 40 VAL A 72 MET A 93 LEU A 141	None	0.83A	1iepB-3oz6A: 21.0	1iepB-3oz6A: 24.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1P2Y_A_NCTA440_1 (CYTOCHROME P450-CAM)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	4 / 7	LEU A 118 VAL A 114 ILE A 101 VAL A 100	None	0.77A	1p2yA-3oz6A: undetectable	1p2yA-3oz6A: 18.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q13_A_TESA501_1 (PROSTAGLANDIN-E2 9-REDUCTASE)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	4 / 6	TYR A 116 TYR A 113 GLU A 341 PRO A 338	None	1.37A	1q13A-3oz6A: undetectable	1q13A-3oz6A: 21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWH_A_BAXA1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	5 / 12	ALA A 38 GLU A 58 LEU A 62 LEU A 125 HIS A 132	None	0.68A	1uwhA-3oz6A: 20.7	1uwhA-3oz6A: 22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WG8_B_SAMB3141_1 (PREDICTED S-ADENOSYLMETHIONINE -DEPENDENT METHYLTRANSFERASE)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	3 / 3	HIS A 110 ASP A 300 ASN A 296	None	0.86A	1wg8B-3oz6A: undetectable	1wg8B-3oz6A: 21.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZQ9_A_SAMA4000_0 (PROBABLE DIMETHYLADENOSINE TRANSFERASE)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	5 / 12	ILE A 230 GLY A 222 LEU A 309 VAL A 114 ILE A 140	None	1.10A	1zq9A-3oz6A: undetectable	1zq9A-3oz6A: 21.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZVA_A_1N1A513_1 (TYROSINE-PROTEIN KINASE LYN)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	7 / 12	ALA A 38 LYS A 40 GLU A 58 VAL A 72 MET A 93 LEU A 141 ALA A 151	None	0.77A	2zvaA-3oz6A: 22.6	2zvaA-3oz6A: 25.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ARU_A_PNXA608_1 (CHITINASE A)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	4 / 6	ASN A 82 ALA A 80 HIS A 6 ASP A 4	None	1.25A	3aruA-3oz6A: undetectable	3aruA-3oz6A: 18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CE6_D_ADND500_2 (ADENOSYLHOMOCYSTEINA SE)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	4 / 5	LEU A 217 GLN A 117 HIS A 126 LEU A 125	None	1.16A	3ce6D-3oz6A: undetectable	3ce6D-3oz6A: 21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CS9_B_NILB600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	5 / 9	VAL A 25 LYS A 40 VAL A 72 LEU A 141 VAL A 150	None	0.75A	3cs9B-3oz6A: 21.2	3cs9B-3oz6A: 22.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CS9_C_NILC600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	5 / 9	VAL A 25 LYS A 40 VAL A 72 MET A 93 VAL A 150	None	0.80A	3cs9C-3oz6A: 20.9	3cs9C-3oz6A: 22.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MSS_D_STID1_2 (TYROSINE-PROTEIN KINASE ABL1)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	4 / 6	VAL A 25 LYS A 40 VAL A 72 MET A 93	None	0.81A	3mssD-3oz6A: 21.0	3mssD-3oz6A: 24.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDU_D_ROCD100_2 (PROTEASE)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	5 / 12	LEU A 225 GLY A 218 ILE A 140 ILE A 119 ILE A 224	None	0.96A	3nduD-3oz6A: undetectable	3nduD-3oz6A: 15.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OEZ_B_STIB601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	7 / 12	VAL A 25 ALA A 38 LYS A 40 GLU A 58 TYR A 92 LEU A 141 ALA A 151	None	0.87A	3oezB-3oz6A: 20.3	3oezB-3oz6A: 24.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_A_1N1A2000_1 (P38A)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	5 / 12	ILE A 295 TRP A 288 ILE A 284 ILE A 230 ALA A 299	None	1.20A	3ohtA-3oz6A: 4.8 3ohtB-3oz6A: 8.3	3ohtA-3oz6A: 33.18 3ohtB-3oz6A: 33.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_B_1N1B2000_1 (P38A)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	5 / 10	ARG A 197 ILE A 201 ILE A 122 ILE A 119 MET A 214	None	1.48A	3ohtA-3oz6A: 7.1 3ohtB-3oz6A: 9.2	3ohtA-3oz6A: 33.18 3ohtB-3oz6A: 33.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OXZ_A_0LIA1_2 (TYROSINE-PROTEIN KINASE ABL1)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	5 / 9	LYS A 40 MET A 93 ARG A 57 LEU A 141 VAL A 150	None	1.47A	3oxzA-3oz6A: 20.8	3oxzA-3oz6A: 24.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QLG_A_1N1A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	8 / 12	VAL A 25 ALA A 38 LYS A 40 GLU A 58 VAL A 72 TYR A 92 LEU A 141 ALA A 151	None	0.75A	3qlgA-3oz6A: 21.0	3qlgA-3oz6A: 24.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RGF_A_BAXA465_1 (CYCLIN-DEPENDENT KINASE 8)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	7 / 12	ALA A 38 GLU A 58 LEU A 62 TYR A 92 LEU A 125 HIS A 132 ALA A 151	None	0.90A	3rgfA-3oz6A: 13.0	3rgfA-3oz6A: 32.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RGF_A_BAXA465_1 (CYCLIN-DEPENDENT KINASE 8)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	8 / 12	VAL A 25 ALA A 38 GLU A 58 LEU A 62 PHE A 90 TYR A 92 HIS A 132 ALA A 151	None	1.08A	3rgfA-3oz6A: 13.0	3rgfA-3oz6A: 32.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TI1_A_B49A299_1 (CYCLIN-DEPENDENT KINASE 2)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	5 / 9	ALA A 38 VAL A 72 PHE A 90 ASP A 96 LEU A 141	None	0.76A	3ti1A-3oz6A: 25.9	3ti1A-3oz6A: 35.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	4 / 5	LYS A 40 VAL A 72 LEU A 141 ASP A 152	None	0.85A	3wzdA-3oz6A: 21.3	3wzdA-3oz6A: 23.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AQL_A_TXCA1452_2 (GUANINE DEAMINASE)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	4 / 5	HIS A 126 LEU A 313 LEU A 221 ASP A 310	None	1.05A	4aqlA-3oz6A: undetectable	4aqlA-3oz6A: 23.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BKJ_B_STIB1000_2 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	4 / 5	LEU A 65 TYR A 92 MET A 93 ARG A 133	None	1.38A	4bkjB-3oz6A: 19.8	4bkjB-3oz6A: 25.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_A_0LIA1000_2 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	4 / 5	VAL A 25 ILE A 71 TYR A 92 MET A 93	None	0.64A	4c8bA-3oz6A: 20.4	4c8bA-3oz6A: 22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_B_0LIB1000_1 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	7 / 12	ALA A 38 GLU A 58 LEU A 62 ILE A 71 HIS A 132 LEU A 141 ALA A 151	None	0.81A	4c8bB-3oz6A: 20.6	4c8bB-3oz6A: 22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_B_0LIB1000_1 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	7 / 12	ALA A 38 LYS A 40 LEU A 62 ILE A 71 HIS A 132 LEU A 141 ALA A 151	None	0.87A	4c8bB-3oz6A: 20.6	4c8bB-3oz6A: 22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_B_0LIB1000_2 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	3 / 3	TYR A 92 MET A 93 ILE A 71	None	0.78A	4c8bB-3oz6A: 20.6	4c8bB-3oz6A: 22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_B_0LIB1000_2 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	3 / 3	TYR A 92 MET A 93 ILE A 140	None	0.87A	4c8bB-3oz6A: 20.6	4c8bB-3oz6A: 22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CSV_A_STIA1265_1 (SRC-ABL TYROSINE KINASE ANCESTOR)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	7 / 12	ALA A 38 GLU A 58 ILE A 61 VAL A 72 TYR A 92 LEU A 141 ALA A 151	None	1.04A	4csvA-3oz6A: 21.1	4csvA-3oz6A: 24.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CSV_A_STIA1265_1 (SRC-ABL TYROSINE KINASE ANCESTOR)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	7 / 12	VAL A 25 ALA A 38 GLU A 58 VAL A 72 TYR A 92 LEU A 141 ALA A 151	None	0.89A	4csvA-3oz6A: 21.1	4csvA-3oz6A: 24.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IAA_A_RTZA401_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	5 / 11	VAL A 25 ALA A 38 LYS A 40 ASP A 96 LEU A 141	None	0.63A	4iaaA-3oz6A: 22.6	4iaaA-3oz6A: 23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K50_I_ACTI507_0 (RNA POLYMERASE 3D-POL)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	3 / 3	LYS A 136 PRO A 137 SER A 138	None	0.33A	4k50I-3oz6A: 0.3	4k50I-3oz6A: 23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_A_8PRA601_1 (RHODOPSIN KINASE)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	4 / 7	ALA A 38 MET A 93 ASP A 96 LEU A 141	None	0.82A	4l9iA-3oz6A: 8.4	4l9iA-3oz6A: 22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MWV_A_BCZA513_1 (NEURAMINIDASE)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	3 / 3	ARG A 373 GLU A 64 ARG A 374	None	0.90A	4mwvA-3oz6A: undetectable	4mwvA-3oz6A: 22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MXX_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	7 / 12	VAL A 25 ALA A 38 LYS A 40 VAL A 72 TYR A 92 MET A 93 LEU A 141	None	0.78A	4mxxB-3oz6A: 20.5	4mxxB-3oz6A: 23.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMN_A_DB8A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	6 / 12	ALA A 38 LYS A 40 GLU A 58 TYR A 92 LEU A 141 ALA A 151	None	0.67A	4qmnA-3oz6A: 24.3	4qmnA-3oz6A: 27.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMN_A_DB8A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	6 / 12	ALA A 38 LYS A 40 GLU A 58 TYR A 92 LEU A 141 ASP A 152	None	0.81A	4qmnA-3oz6A: 24.3	4qmnA-3oz6A: 27.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TYJ_A_0LIA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	5 / 12	ALA A 38 GLU A 58 HIS A 132 LEU A 141 ALA A 151	None	0.70A	4tyjA-3oz6A: 20.7	4tyjA-3oz6A: 27.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XLI_A_1N1A601_1 (NON-SPECIFIC PROTEIN-TYROSINE KINASE)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	8 / 12	ALA A 38 LYS A 40 GLU A 58 VAL A 72 TYR A 92 MET A 93 LEU A 141 ALA A 151	None	0.75A	4xliA-3oz6A: 23.0	4xliA-3oz6A: 24.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5L2I_A_LQQA900_1 (CYCLIN-DEPENDENT KINASE 6)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	6 / 12	ALA A 38 VAL A 72 PHE A 90 ASP A 96 LEU A 141 ALA A 151	None	0.73A	5l2iA-3oz6A: 13.9	5l2iA-3oz6A: 30.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5L2T_A_6ZZA900_1 (CYCLIN-DEPENDENT KINASE 6)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	7 / 12	VAL A 25 ALA A 38 VAL A 72 PHE A 90 ASP A 96 LEU A 141 ALA A 151	None	0.91A	5l2tA-3oz6A: 14.3	5l2tA-3oz6A: 30.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MO4_A_NILA601_2 (TYROSINE-PROTEIN KINASE ABL1)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	5 / 12	ALA A 38 VAL A 72 HIS A 132 LEU A 141 ALA A 151	None	0.78A	5mo4A-3oz6A: 18.6	5mo4A-3oz6A: 19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZ0_A_ZLDA301_0 (HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	5 / 12	GLY A 204 ILE A 169 PHE A 262 THR A 166 VAL A 165	None	1.39A	5nz0A-3oz6A: undetectable	5nz0A-3oz6A: 21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	3 / 3	LYS A 40 LEU A 141 ASP A 152	None	0.71A	5zv2A-3oz6A: 21.6	5zv2A-3oz6A: 11.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	3 / 3	TYR A 92 LEU A 141 ASP A 152	None	0.39A	5zv2B-3oz6A: 21.2	5zv2B-3oz6A: 11.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6ECT_A_SAMA1300_0 (STIE PROTEIN)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	5 / 12	GLY A 222 ASP A 300 VAL A 115 LEU A 118 ILE A 119	None	0.97A	6ectA-3oz6A: undetectable	6ectA-3oz6A: 20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6ECX_A_SAMA1301_0 (STIE PROTEIN)	3oz6	MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE/THREONINE PROTEIN KINASE (Cryptosporidium parvum)	5 / 12	GLY A 222 ASP A 300 VAL A 115 LEU A 118 ILE A 119	None	1.00A	6ecxA-3oz6A: undetectable	6ecxA-3oz6A: 20.51

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1HPV_B_478B200_1","HIV-1 PROTEASE;HIV-1 PROTEASE","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",5,"LEU A 225;GLY A 218;ILE A 140;ILE A 119;ILE A 224","None","1.00A","1hpvA-3oz6A:undetectable","1hpvA-3oz6A:14.78"],["1IEP_B_STIB202_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",4,"LYS A  40;VAL A  72;MET A  93;LEU A 141","None","0.83A","1iepB-3oz6A:21.0","1iepB-3oz6A:24.12"],["1P2Y_A_NCTA440_1","CYTOCHROME P450-CAM","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",4,"LEU A 118;VAL A 114;ILE A 101;VAL A 100","None","0.77A","1p2yA-3oz6A:undetectable","1p2yA-3oz6A:18.12"],["1Q13_A_TESA501_1","PROSTAGLANDIN-E2 9-REDUCTASE","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",4,"TYR A 116;TYR A 113;GLU A 341;PRO A 338","None","1.37A","1q13A-3oz6A:undetectable","1q13A-3oz6A:21.89"],["1UWH_A_BAXA1723_1","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",5,"ALA A  38;GLU A  58;LEU A  62;LEU A 125;HIS A 132","None","0.68A","1uwhA-3oz6A:20.7","1uwhA-3oz6A:22.86"],["1WG8_B_SAMB3141_1","PREDICTED S-ADENOSYLMETHIONINE-DEPENDENT METHYLTRANSFERASE","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",3,"HIS A 110;ASP A 300;ASN A 296","None","0.86A","1wg8B-3oz6A:undetectable","1wg8B-3oz6A:21.27"],["1ZQ9_A_SAMA4000_0","PROBABLE DIMETHYLADENOSINE TRANSFERASE","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",5,"ILE A 230;GLY A 222;LEU A 309;VAL A 114;ILE A 140","None","1.10A","1zq9A-3oz6A:undetectable","1zq9A-3oz6A:21.77"],["2ZVA_A_1N1A513_1","TYROSINE-PROTEIN KINASE LYN","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",7,"ALA A  38;LYS A  40;GLU A  58;VAL A  72;MET A  93;LEU A 141;ALA A 151","None","0.77A","2zvaA-3oz6A:22.6","2zvaA-3oz6A:25.12"],["3ARU_A_PNXA608_1","CHITINASE A","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",4,"ASN A  82;ALA A  80;HIS A   6;ASP A   4","None","1.25A","3aruA-3oz6A:undetectable","3aruA-3oz6A:18.46"],["3CE6_D_ADND500_2","ADENOSYLHOMOCYSTEINASE","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",4,"LEU A 217;GLN A 117;HIS A 126;LEU A 125","None","1.16A","3ce6D-3oz6A:undetectable","3ce6D-3oz6A:21.30"],["3CS9_B_NILB600_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",5,"VAL A  25;LYS A  40;VAL A  72;LEU A 141;VAL A 150","None","0.75A","3cs9B-3oz6A:21.2","3cs9B-3oz6A:22.81"],["3CS9_C_NILC600_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",5,"VAL A  25;LYS A  40;VAL A  72;MET A  93;VAL A 150","None","0.80A","3cs9C-3oz6A:20.9","3cs9C-3oz6A:22.81"],["3MSS_D_STID1_2","TYROSINE-PROTEIN KINASE ABL1","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",4,"VAL A  25;LYS A  40;VAL A  72;MET A  93","None","0.81A","3mssD-3oz6A:21.0","3mssD-3oz6A:24.12"],["3NDU_D_ROCD100_2","PROTEASE","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",5,"LEU A 225;GLY A 218;ILE A 140;ILE A 119;ILE A 224","None","0.96A","3nduD-3oz6A:undetectable","3nduD-3oz6A:15.24"],["3OEZ_B_STIB601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",7,"VAL A  25;ALA A  38;LYS A  40;GLU A  58;TYR A  92;LEU A 141;ALA A 151","None","0.87A","3oezB-3oz6A:20.3","3oezB-3oz6A:24.94"],["3OHT_A_1N1A2000_1","P38A;P38A","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",5,"ILE A 295;TRP A 288;ILE A 284;ILE A 230;ALA A 299","None","1.20A","3ohtA-3oz6A:4.8;3ohtB-3oz6A:8.3","3ohtA-3oz6A:33.18;3ohtB-3oz6A:33.18"],["3OHT_B_1N1B2000_1","P38A;P38A","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",5,"ARG A 197;ILE A 201;ILE A 122;ILE A 119;MET A 214","None","1.48A","3ohtA-3oz6A:7.1;3ohtB-3oz6A:9.2","3ohtA-3oz6A:33.18;3ohtB-3oz6A:33.18"],["3OXZ_A_0LIA1_2","TYROSINE-PROTEIN KINASE ABL1","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",5,"LYS A  40;MET A  93;ARG A  57;LEU A 141;VAL A 150","None","1.47A","3oxzA-3oz6A:20.8","3oxzA-3oz6A:24.37"],["3QLG_A_1N1A601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",8,"VAL A  25;ALA A  38;LYS A  40;GLU A  58;VAL A  72;TYR A  92;LEU A 141;ALA A 151","None","0.75A","3qlgA-3oz6A:21.0","3qlgA-3oz6A:24.94"],["3RGF_A_BAXA465_1","CYCLIN-DEPENDENT KINASE 8","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",7,"ALA A  38;GLU A  58;LEU A  62;TYR A  92;LEU A 125;HIS A 132;ALA A 151","None","0.90A","3rgfA-3oz6A:13.0","3rgfA-3oz6A:32.55"],["3RGF_A_BAXA465_1","CYCLIN-DEPENDENT KINASE 8","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",8,"VAL A  25;ALA A  38;GLU A  58;LEU A  62;PHE A  90;TYR A  92;HIS A 132;ALA A 151","None","1.08A","3rgfA-3oz6A:13.0","3rgfA-3oz6A:32.55"],["3TI1_A_B49A299_1","CYCLIN-DEPENDENT KINASE 2","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",5,"ALA A  38;VAL A  72;PHE A  90;ASP A  96;LEU A 141","None","0.76A","3ti1A-3oz6A:25.9","3ti1A-3oz6A:35.34"],["3WZD_A_LEVA1201_2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",4,"LYS A  40;VAL A  72;LEU A 141;ASP A 152","None","0.85A","3wzdA-3oz6A:21.3","3wzdA-3oz6A:23.92"],["4AQL_A_TXCA1452_2","GUANINE DEAMINASE","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",4,"HIS A 126;LEU A 313;LEU A 221;ASP A 310","None","1.05A","4aqlA-3oz6A:undetectable","4aqlA-3oz6A:23.09"],["4BKJ_B_STIB1000_2","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",4,"LEU A  65;TYR A  92;MET A  93;ARG A 133","None","1.38A","4bkjB-3oz6A:19.8","4bkjB-3oz6A:25.18"],["4C8B_A_0LIA1000_2","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",4,"VAL A  25;ILE A  71;TYR A  92;MET A  93","None","0.64A","4c8bA-3oz6A:20.4","4c8bA-3oz6A:22.80"],["4C8B_B_0LIB1000_1","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",7,"ALA A  38;GLU A  58;LEU A  62;ILE A  71;HIS A 132;LEU A 141;ALA A 151","None","0.81A","4c8bB-3oz6A:20.6","4c8bB-3oz6A:22.80"],["4C8B_B_0LIB1000_1","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",7,"ALA A  38;LYS A  40;LEU A  62;ILE A  71;HIS A 132;LEU A 141;ALA A 151","None","0.87A","4c8bB-3oz6A:20.6","4c8bB-3oz6A:22.80"],["4C8B_B_0LIB1000_2","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",3,"TYR A  92;MET A  93;ILE A  71","None","0.78A","4c8bB-3oz6A:20.6","4c8bB-3oz6A:22.80"],["4C8B_B_0LIB1000_2","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",3,"TYR A  92;MET A  93;ILE A 140","None","0.87A","4c8bB-3oz6A:20.6","4c8bB-3oz6A:22.80"],["4CSV_A_STIA1265_1","SRC-ABL TYROSINE KINASE ANCESTOR","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",7,"ALA A  38;GLU A  58;ILE A  61;VAL A  72;TYR A  92;LEU A 141;ALA A 151","None","1.04A","4csvA-3oz6A:21.1","4csvA-3oz6A:24.81"],["4CSV_A_STIA1265_1","SRC-ABL TYROSINE KINASE ANCESTOR","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",7,"VAL A  25;ALA A  38;GLU A  58;VAL A  72;TYR A  92;LEU A 141;ALA A 151","None","0.89A","4csvA-3oz6A:21.1","4csvA-3oz6A:24.81"],["4IAA_A_RTZA401_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",5,"VAL A  25;ALA A  38;LYS A  40;ASP A  96;LEU A 141","None","0.63A","4iaaA-3oz6A:22.6","4iaaA-3oz6A:23.08"],["4K50_I_ACTI507_0","RNA POLYMERASE 3D-POL","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",3,"LYS A 136;PRO A 137;SER A 138","None","0.33A","4k50I-3oz6A:0.3","4k50I-3oz6A:23.27"],["4L9I_A_8PRA601_1","RHODOPSIN KINASE","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",4,"ALA A  38;MET A  93;ASP A  96;LEU A 141","None","0.82A","4l9iA-3oz6A:8.4","4l9iA-3oz6A:22.12"],["4MWV_A_BCZA513_1","NEURAMINIDASE","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",3,"ARG A 373;GLU A  64;ARG A 374","None","0.90A","4mwvA-3oz6A:undetectable","4mwvA-3oz6A:22.30"],["4MXX_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",7,"VAL A  25;ALA A  38;LYS A  40;VAL A  72;TYR A  92;MET A  93;LEU A 141","None","0.78A","4mxxB-3oz6A:20.5","4mxxB-3oz6A:23.91"],["4QMN_A_DB8A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",6,"ALA A  38;LYS A  40;GLU A  58;TYR A  92;LEU A 141;ALA A 151","None","0.67A","4qmnA-3oz6A:24.3","4qmnA-3oz6A:27.36"],["4QMN_A_DB8A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",6,"ALA A  38;LYS A  40;GLU A  58;TYR A  92;LEU A 141;ASP A 152","None","0.81A","4qmnA-3oz6A:24.3","4qmnA-3oz6A:27.36"],["4TYJ_A_0LIA801_1","FIBROBLAST GROWTH FACTOR RECEPTOR 4","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",5,"ALA A  38;GLU A  58;HIS A 132;LEU A 141;ALA A 151","None","0.70A","4tyjA-3oz6A:20.7","4tyjA-3oz6A:27.01"],["4XLI_A_1N1A601_1","NON-SPECIFIC PROTEIN-TYROSINE KINASE","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",8,"ALA A  38;LYS A  40;GLU A  58;VAL A  72;TYR A  92;MET A  93;LEU A 141;ALA A 151","None","0.75A","4xliA-3oz6A:23.0","4xliA-3oz6A:24.60"],["5L2I_A_LQQA900_1","CYCLIN-DEPENDENT KINASE 6","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",6,"ALA A  38;VAL A  72;PHE A  90;ASP A  96;LEU A 141;ALA A 151","None","0.73A","5l2iA-3oz6A:13.9","5l2iA-3oz6A:30.67"],["5L2T_A_6ZZA900_1","CYCLIN-DEPENDENT KINASE 6","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",7,"VAL A  25;ALA A  38;VAL A  72;PHE A  90;ASP A  96;LEU A 141;ALA A 151","None","0.91A","5l2tA-3oz6A:14.3","5l2tA-3oz6A:30.67"],["5MO4_A_NILA601_2","TYROSINE-PROTEIN KINASE ABL1","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",5,"ALA A  38;VAL A  72;HIS A 132;LEU A 141;ALA A 151","None","0.78A","5mo4A-3oz6A:18.6","5mo4A-3oz6A:19.72"],["5NZ0_A_ZLDA301_0","HTH-TYPE TRANSCRIPTIONAL REGULATOR ETHR","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",5,"GLY A 204;ILE A 169;PHE A 262;THR A 166;VAL A 165","None","1.39A","5nz0A-3oz6A:undetectable","5nz0A-3oz6A:21.13"],["5ZV2_A_LEVA801_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",3,"LYS A  40;LEU A 141;ASP A 152","None","0.71A","5zv2A-3oz6A:21.6","5zv2A-3oz6A:11.32"],["5ZV2_B_LEVB801_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",3,"TYR A  92;LEU A 141;ASP A 152","None","0.39A","5zv2B-3oz6A:21.2","5zv2B-3oz6A:11.32"],["6ECT_A_SAMA1300_0","STIE PROTEIN","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",5,"GLY A 222;ASP A 300;VAL A 115;LEU A 118;ILE A 119","None","0.97A","6ectA-3oz6A:undetectable","6ectA-3oz6A:20.50"],["6ECX_A_SAMA1301_0","STIE PROTEIN","3oz6","MITOGEN-ACTIVATED PROTEIN KINASE 1, SERINE\/THREONINE PROTEIN KINASE","Cryptosporidium parvum",5,"GLY A 222;ASP A 300;VAL A 115;LEU A 118;ILE A 119","None","1.00A","6ecxA-3oz6A:undetectable","6ecxA-3oz6A:20.51"]]